Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun;12(2):81-86.
doi: 10.1007/BF02480777.

Attenuation of nitric oxide-stimulated soluble guanylyl cyclase from the rat brain by halogenated volatile anesthetics

Eiji Masaki  1 , Ichiro Kondo  2
Affiliations

Attenuation of nitric oxide-stimulated soluble guanylyl cyclase from the rat brain by halogenated volatile anesthetics

Eiji Masaki et al. J Anesth. 1998 Jun.

Abstract

Purpose: The present study was undertaken to examine whether interaction between halogenated volatile anesthetics and nitric oxide (NO) at soluble guanylyl cyclase (sGC) would occur in rat brain.

Methods: A soluble brain fraction was prepared from extensively perfused Sprague-Dawley rat brains by centrifugation and used as the source of sGC. sGC was incubated with NO and halogenated volatile anesthetics, and cGMP production was determined by enzyme immunoassay in aliquots of the supernatant.

Results: Halothane and sevoflurane produced significant (P<0.01) and dose-dependent inhibition of NO-stimulated sGC activity over a range of NO concentrations (2×10-9 to 2×10-5 M). Among the anesthetics, halothane tended to have a large inhibitory effect on NO-stimulated sGC activity, which was, however, not significant. sGC activity was also inhibited by both anesthetics (P<0.05) in the absence of NO stimulation. GTP dose-dependently increased both NO-stimulated and-nonstimulated sGC activities. Halothane and sevoflurane decreased these activities (P<0.01), but the inhibition by these anesthetics was not significant at higher GTP concentrations.

Conclusion: These results suggest that halogenated volatile anesthetics can attenuate the activity of NO-stimulated sGC by competing with NO for the NO binding site on the enzyme.

Keywords: Ferrous iron; Guanylyl cyclase; Halogenated volatile anesthetics; Nitric oxide.

PubMed Disclaimer

References

    1. Anesthesiology. 1995 Jan;82(1):205-13 - PubMed
    1. Neuron. 1992 Jan;8(1):3-11 - PubMed
    1. Nature. 1988 Nov 24;336(6197):385-8 - PubMed
    1. Biochem Pharmacol. 1971 Feb;20(2):463-70 - PubMed
    1. Nature. 1988 Jun 16;333(6174):664-6 - PubMed